Jean‐Mathieu Beauregard

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial

Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 176 citations

Neuroendocrine Tumours, Initial Results, Engineering +13

Quantitative 177 Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system

Jean‐Mathieu Beauregard, Michael S. Hofman, Jucilene Maria Pereira et al. · Cancer Imaging · 2011 · 144 citations · Full text

The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy

Jean‐Mathieu Beauregard, Michael S. Hofman, Grace Kong et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 143 citations

Tumor Biology, Oncology, Medicine +12

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study

Michela Del Prete, François-Alexandre Buteau, Jean‐Mathieu Beauregard · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 111 citations

Neuroendocrine Tumours, Neuro-oncology, Oncology +12

⁶⁸Ga PET/CT Ventilation–Perfusion Imaging for Pulmonary Embolism: A Pilot Study with Comparison to Conventional Scintigraphy

Michael S. Hofman, Jean‐Mathieu Beauregard, Thomas W. Barber et al. · Journal of Nuclear Medicine · 2011 · 103 citations · Full text